| Biliary Tract Adenocarcinoma studied in …STUDIED_INderived10 of 28show all (up to 200) |
|---|
| → studied in | NCT05482516Phase 3 · recruiting Evaluating Novel Therapies in ctDNA Positive GI Cancers · condition mapped ONTOLOGY_EXACT · 28 trials mapped (9 active) | — | — | Biliary Tract Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07161869recruiting Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) · condition mapped ONTOLOGY_EXACT · 28 trials mapped (9 active) | — | — | Biliary Tract Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07282912Phase 2 · recruiting Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels · condition mapped ONTOLOGY_EXACT · 28 trials mapped (9 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07120295Phase 4 · recruiting Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories · condition mapped ONTOLOGY_EXACT · 28 trials mapped (9 active) | — | — | Bile Duct Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07765433Phase 2/Phase 3 · not yet recruiting Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer · condition mapped CURATED_BROADER · 28 trials mapped (9 active) | — | — | Biliary Tract Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05285358Phase 1 · recruiting Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases · condition mapped ONTOLOGY_EXACT · 28 trials mapped (9 active) | — | — | Distal Bile Duct Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03257761Phase 1 · active not recruiting Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (9 active) | — | — | Extrahepatic Bile Duct Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04042831Phase 2 · active not recruiting Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations · condition mapped ONTOLOGY_EXACT · 28 trials mapped (9 active) | — | — | Bile Duct Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03044587Phase 2 · completed Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (9 active) | — | — | Biliary Tract Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04941287Phase 2 · active not recruiting Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer · condition mapped CURATED_BROADER · 28 trials mapped (9 active) | — | — | Distal Bile Duct Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |